Technical Analysis for EPI - Essa Pharma Inc.

Grade Last Price % Change Price Change
grade C 4.45 -6.32% -0.300
EPI closed down 6.32 percent on Thursday, March 21, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical EPI trend table...

Date Alert Name Type % Chg
Mar 21 Fell Below 50 DMA Bearish 0.00%
Mar 21 MACD Bearish Centerline Cross Bearish 0.00%
Mar 21 Bollinger Band Squeeze Range Contraction 0.00%
Mar 21 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 21 Below Lower BB Weakness 0.00%
Mar 21 Down 3 Days in a Row Weakness 0.00%
Mar 21 Gapped Down Weakness 0.00%
Mar 21 Lower Bollinger Band Touch Weakness 0.00%
Mar 19 Fell Below 20 DMA Bearish -6.32%
Mar 19 Bollinger Band Squeeze Range Contraction -6.32%

Older signals for EPI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues.
Chemistry Organic Compounds Chemical Compounds Pharmacokinetics
Is EPI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.15
52 Week Low 0.195
Average Volume 2,184
200-Day Moving Average 4.1454
50-Day Moving Average 4.715
20-Day Moving Average 4.84
10-Day Moving Average 4.816
Average True Range 0.2003
ADX 17.8
+DI 23.2197
-DI 45.2186
Chandelier Exit (Long, 3 ATRs ) 4.5391
Chandelier Exit (Short, 3 ATRs ) 5.0509
Upper Bollinger Band 5.1382
Lower Bollinger Band 4.5418
Percent B (%b) -0.15
BandWidth 12.322314
MACD Line -0.0148
MACD Signal Line 0.0366
MACD Histogram -0.0514
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.660
Resistance 3 (R3) 4.683 4.637 4.625
Resistance 2 (R2) 4.637 4.583 4.625 4.613
Resistance 1 (R1) 4.543 4.550 4.520 4.520 4.602
Pivot Point 4.497 4.497 4.485 4.485 4.497
Support 1 (S1) 4.403 4.443 4.380 4.380 4.298
Support 2 (S2) 4.357 4.410 4.345 4.287
Support 3 (S3) 4.263 4.357 4.275
Support 4 (S4) 4.240